Katherine H. Saunders, MD, DABOM | Source | Co-Founder and Executive Vice President at Intellihealth
Katherine H. Saunders, MD, DABOM
Dr. Katherine H. Saunders is a physician entrepreneur and a leading expert in Obesity Medicine. She is on the cutting edge of effective and compassionate obesity treatment. Dr. Saunders practices at Intellihealth’s clinical services affiliate, Flyte Medical, and she teaches at Weill Cornell Medicine.
Dr. Saunders received her undergraduate degree Phi Beta Kappa/Summa Cum Laude from Dartmouth College and her medical degree from Weill Cornell Medical College, where she became a member of the Alpha Omega Alpha Honor Medical Society. She completed her internship and residency training in Internal Medicine (Primary Care) at New York-Presbyterian Hospital/Weill Cornell Medicine, where she served as ambulatory chief resident. Dr. Saunders was the first clinical fellow in Obesity Medicine at the Comprehensive Weight Control Center at Weill Cornell Medicine.
Dr. Saunders is a diplomate of the American Board of Internal Medicine and the American Board of Obesity Medicine. She hosts the Weight Matters podcast with Dr. Louis Aronne, she regularly speaks at international conferences, and she publishes extensively on Obesity Medicine and weight management. She has authored more than 50 peer-reviewed articles and book chapters. Additionally, she has been featured in multiple national media outlets, including Associated Press, Forbes, Women’s Health, USA Today, Parade, and Medical News Today. Dr. Saunders also makes frequent guest appearances on a variety of podcasts and radio shows.
Dr. Saunders’ recent awards and recognition include the Women at Weill Investment Competition, Brown Brothers Harriman 22 Women to Watch in 2022 and Medika Life Top 30 Influencers Transforming Wellness in 2023.
-
Weill Cornell Medicine
Clinical Assistant Professor of Medicine -
Intellihealth (https://www.intellihealth.co/)
Co-Founder and Executive Vice President
-
Mounjaro, Zepbound: What Happens to Your Body When You Stop Taking Weight Loss Drugs
People are likely to experience several biological and psychological changes shortly after they stop taking GLP-1 drugs like Mounjaro and Zepbound.
Article -
Thinking About Trying Mounjaro or Zepbound? Here's What You Can Expect Week by Week
Obesity specialists give realistic expectations of what to expect on a typical Mounjaro journey.
Article -
Ozempic, Wegovy, Mounjaro: How to Maintain Weight After Stopping
While most people gain weight back after stopping medications like Ozempic, Mounjaro, and Wegovy, health experts say there are steps you can take to reduce your risk.
Article
-
Exciting results from studies into new medications offer promise to the millions of Americans who have excess weight. “We need as many tools as we can get in our armamentarium so that we have effective options for everybody,” says Dr. Katherine Saunders. - U.S. News & World Report
-
Given the choice between a weekly shot or a daily pill, Dr. Katherine Saunders says some patients would be “thrilled” to opt for the oral alternative. This is especially true if the studies showing weight loss on par with injectables prove out in the wider population. - Associated Press
-
While some patients experience stomach upset and other side effects when taking Ozempic and Wegovy, “Extreme nausea is quite rare among our patients because we begin with a low dose and titrate up slowly and conservatively as needed and tolerated,” Dr. Katherine Saunders says. - Parade
